James is a Director Analyst at Gartner, specialising in front‑end innovation, AI‑enabled R&D, and digital transformation across scientific and product‑driven organisations. A Chartered Scientist with deep expertise in AI, digital health, and nutraceutical innovation, James brings a practitioner’s understanding of how scientific, technical, and commercial forces intersect. His research focuses on front‑end innovation models, decision intelligence, and digital operating frameworks that help organisations identify high‑value opportunities earlier, accelerate concept‑to‑pipeline translation, and strengthen strategic portfolio choices. He is experienced at shaping long‑term R&D strategies, guiding M&A and venture investment decisions, and turning board‑level ambition into executable programmes that deliver tangible impact. James is a trusted advisor to senior leadership teams navigating innovation governance, digital transformation, and future‑focused growth.
Prior to joining Gartner, James led the Scientific Foresights programme at a global FTSE 100 company, shaping long‑term commercial and regulatory strategy through regulatory science, deep analysis of emerging technology, and market signals. He built and managed an external innovation ecosystem spanning startups, academia, and research networks, enabling strategic partnerships and investment opportunities that strengthened the enterprise’s future growth agenda. James’ scientific foundation spans over a decade of clinical and translational research across the UK and the United States. Before moving into corporate R&D, he spent many years working in clinical research environments focused on neuroscience, sleep and tobacco harm reduction, contributing to studies that informed both academic practice and public health. Earlier in his career, James served as a Research Associate at the Oklahoma Centre for Neuroscience, where he contributed to federally funded programmes supporting U.S. veterans returning from active duty.
Leading Digital Transformation — London Business School;
PGCert Business Administration (Executive MBA) - INPD & University of Chester;
PhD Neuroscience - University of Surrey;
BSc (Hons) Biomedical Science - University of Surrey.
1. Early‑Stage Technology Evaluation; 2) Front‑End Innovation Processes ; 3) Digital Transformation; 3) Innovation Ecosystem Strategy; 4) Innovation Governance & Executive Decision Support